Frontier Clinical Research, LLC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Migraine2 trials
• Obesity1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Ipsen2 trials
• Eli Lilly and Company1 trial

Running trials

• Recruiting

  A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  NCT07794579· Phase 3· Eli Lilly and Company· Source

  Contact: Jeffry Pilney (principal investigator)

• Active, not recruiting

  A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

  NCT06047444· Phase 3· Ipsen· Source

• Active, not recruiting

  A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

  NCT06047457· Phase 3· Ipsen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity1 recruiting